In a double-blind , randomized , placebo-controlled , within-group study design , 26 healthy and 16 highly socially anxious ( HSA ) male volunteers ( within the HSA group , 10 were diagnosed with generalized social anxiety disorder ) were administered 24 IU of oxytocin or placebo to investigate attentional processing in social anxiety .